Get Smart: Specific Drug Information for Extended-Release and Long-Acting Opioids
Pain Management
Credits:
0.5 ACPE 0.5 ANCC Contact Hours 0.5 AMA PRA Category 1 Credit(s) ™
0.5 ACPE 0.5 ANCC Contact Hours 0.5 AMA PRA Category 1 Credit(s) ™
Launch Date:
July 13, 2017
July 13, 2017
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
This activity is intended for primary care clinicians, pain management specialists, nurse practitioners, physician assistants, nurses, pharmacists, and any other clinicians involved in the care of patients on extended-release/long-acting (ER/LA) opioid therapy.
Relevant Terms:
Opioids; misuse; abuse; diversion; assessment; chronic pain
Yvonne M. D'Arcy, MS, CRNP, CNS
Yvonne M. D'Arcy, MS, CRNP, CNS
Pain Management and Palliative Care
Suburban Hospital
Johns Hopkins Medicine
Bethesda, Maryland
Bio
Ms. D’Arcy, MS, CRNP, CNS, FAANP is a pain management and palliative care nurse practitioner with 20 years of experience. She practiced most recently at Suburban Hospital-Johns Hopkins Medicine in Bethesda, Maryland. Ms D’Arcy received her nursing education at Viterbo University in La Crosse, Wisconsin, and Winona State University in Winona, Minnesota.
Ms D’Arcy is a member of a number of professional societies, including the American Association of Nurse Practitioners where she was recently inducted as a Fellow. She serves on the editorial boards for such journals as the Journal for Nurse Practitioners, Nursing, and Pain Management News.
Ms D’Arcy has authored or co-authored more than 100 articles and 10 books, including the award-winning Compact Clinical Guide to Cancer Pain Management: An Evidence-Based Approach for Nurses, How to Manage Pain in the Elderly, and How to Manage Pain in Addicted Patients. She has given more than 170 presentations at facilities and professional society meetings nationwide.
Michael Clark, MD
Michael Clark, MD Associate Professor & Director Chronic Pain Treatment Program Department of Psychiatry & Behavioral Sciences The Johns Hopkins Hospital Baltimore, MD
Bio
Associate Professor & Director
Chronic Pain Treatment Program
Department of Psychiatry & Behavioral Sciences
The Johns Hopkins Hospital
Baltimore, MD
Dr. Clark is Associate Professor and Director of the Chronic Pain Treatment Program in the Department of Psychiatry and Behavioral Medicine and has joint appointments in the Departments of Otolaryngology-Head & Neck Surgery in the School of Medicine and of Mental Hygiene in the Bloomberg School of Hygiene and Public Health.
A fellow of the Academy of Psychosomatic Medicine, Dr. Clark currently devotes his research work to psychiatric phenomenology of sensory abnormalities such as chronic dizziness and pain, including studies on neuropathic pain. He serves on the National Institutes of Health Division of Research Grants Risk Prevention and Health Behavior Study Section.
| 1. | Participants will demonstrate the ability to identify product-specific drug information concerning ER/LA opioid analgesics |
| 1. | Participants will demonstrate the ability to identify product-specific drug information concerning ER/LA opioid analgesics |
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and DKBMed. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and DKBMed. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
ABIM MOC:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Credit Designation
The Postgraduate Institute for Medicine designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
Postgraduate Instutite for Medicine is accreditecd by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Postgraduate Instutite for Medicine is accreditecd by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.Postgraduate Institue for Medicine designates tis continuing education activity for .5 contact hour(s) (0.5 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - 809-9999-17-710-H01-P)
Type of Activity
Knowledge
Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service withiin 4 weeks.
Pharmacists: Your official record of ACPE credit will be generated through the CPE Monitor System. The certificate printed after completing the evaluation for this activity is for personal tracking purposess only.
Target Audience
This activity is intended for primary care clinicians, pain management specialists, nurse practitioners, physician assistants, nurses, pharmacists, and any other clinicians involved in the care of patients on extended-release/long-acting (ER/LA) opioid therapy.
Educational Support
This activity is intended for primary care clinicians, pain management specialists, nurse practitioners, physician assistants, nurses, pharmacists, and any other clinicians involved in the care of patients on extended-release/long-acting (ER/LA) opioid therapy.
Educational Support
This activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Faculty
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Michael R. Clark, MD, MPH, MBA, Consulting fees from Depomed, Collegium, Endo Advisory Boards
Yvonne D'Arcy, MS, CRNP, CNS, FAANP, Consulting Fees: Ortho McNeil, Purdue-unbranded, Practicing Clinicians-Chronic pain, Teva. Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents: Purdue, Ortho McNeil-unbranded. Royalty: Lippincott Williams & Wilkins Publishing, Springer Publishing
Planners
Michael R. Clark, MD, MPH, MBA, Consulting fees from Depomed, Collegium, Endo Advisory Boards
Yvonne D'Arcy, MS, CRNP, CNS, FAANP, Consulting Fees: Ortho McNeil, Purdue-unbranded, Practicing Clinicians-Chronic pain, Teva. Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents: Purdue, Ortho McNeil-unbranded. Royalty: Lippincott Williams & Wilkins Publishing, Springer Publishing
Planners
The Planning Committee for this activity included Nicole Fortune and Stan Pogroszewski of DKBmed, LLC. None of the aforementioned members of the Planning Committee have any significant relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation and Request for Credit
Please review the program in its entiretly and successfully complete the posttest with at least 70% to recieve a certificate of credit.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6+ for Mac OSX 10.7 and above For video playback, install the latest version of Flash or Quicktime. | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |
© 2007-2024 HealthCourse, Inc. All rights reserved.
